Literature DB >> 34750543

How protein-based COVID vaccines could change the pandemic.

Elie Dolgin.   

Abstract

Entities:  

Keywords:  Immunology; Public health; SARS-CoV-2; Vaccines

Mesh：

Substances：

Year:  2021        PMID： 34750543     DOI： 10.1038/d41586-021-03025-0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  2 in total

1.  Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial.

Authors:  Peter Richmond; Lara Hatchuel; Min Dong; Brenda Ma; Branda Hu; Igor Smolenov; Ping Li; Peng Liang; Htay Htay Han; Joshua Liang; Ralf Clemens
Journal:  Lancet       Date:  2021-01-29       Impact factor: 79.321

2.  Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine.

Authors:  Cheryl Keech; Gary Albert; Iksung Cho; Andreana Robertson; Patricia Reed; Susan Neal; Joyce S Plested; Mingzhu Zhu; Shane Cloney-Clark; Haixia Zhou; Gale Smith; Nita Patel; Matthew B Frieman; Robert E Haupt; James Logue; Marisa McGrath; Stuart Weston; Pedro A Piedra; Chinar Desai; Kathleen Callahan; Maggie Lewis; Patricia Price-Abbott; Neil Formica; Vivek Shinde; Louis Fries; Jason D Lickliter; Paul Griffin; Bethanie Wilkinson; Gregory M Glenn
Journal:  N Engl J Med       Date:  2020-09-02       Impact factor: 91.245
  2 in total
  10 in total

Review 1.  Development of COVID 19 vaccine: A summarized review on global trials, efficacy, and effectiveness on variants.

Authors:  Satyendra Prakash
Journal:  Diabetes Metab Syndr       Date:  2022-04-08

Review 2.  Severe Acute Respiratory Syndrome Type 2-Causing Coronavirus: Variants and Preventive Strategies.

Authors:  Mehmet Onur Aydogdu; Jennifer L Rohn; Nazila V Jafari; Francis Brako; Shervanthi Homer-Vanniasinkam; Mohan Edirisinghe
Journal:  Adv Sci (Weinh)       Date:  2022-01-17       Impact factor: 16.806

3.  Spherical nucleic acids as an infectious disease vaccine platform.

Authors:  Michelle H Teplensky; Max E Distler; Caroline D Kusmierz; Michael Evangelopoulos; Haley Gula; Derek Elli; Anastasia Tomatsidou; Vlad Nicolaescu; Ian Gelarden; Anjana Yeldandi; Daniel Batlle; Dominique Missiakas; Chad A Mirkin
Journal:  Proc Natl Acad Sci U S A       Date:  2022-03-21       Impact factor: 12.779

4.  Selective reversed-phase high-performance liquid chromatography method for the determination of intact SARS-CoV-2 spike protein.

Authors:  Barry Lorbetskie; Taryn White; Marybeth Creskey; Xu Zhang; Michel Girard; Roger Y Tam; Simon Sauvé; Huixin Lu
Journal:  J Chromatogr A       Date:  2022-08-16       Impact factor: 4.601

Review 5.  Towards novel nano-based vaccine platforms for SARS-CoV-2 and its variants of concern: Advances, challenges and limitations.

Authors:  Sally A Helmy; Rasha M El-Morsi; Soha A M Helmy; Soha M El-Masry
Journal:  J Drug Deliv Sci Technol       Date:  2022-09-08       Impact factor: 5.062

6.  NVX-CoV2373, a protein-based vaccine against SARS-CoV-2 infection.

Authors:  Sabina Vohra-Miller; Ilan S Schwartz
Journal:  CMAJ       Date:  2022-09-12       Impact factor: 16.859

7.  RBD-VLP Vaccines Adjuvanted with Alum or SWE Protect K18-hACE2 Mice against SARS-CoV-2 VOC Challenge.

Authors:  Ting Y Wong; Brynnan P Russ; Katherine S Lee; Olivia A Miller; Jason Kang; Melissa Cooper; Michael T Winters; Sergio A Rodriguez-Aponte; Neil C Dalvie; Ryan S Johnston; Nathaniel A Rader; Zeriel Y Wong; Holly A Cyphert; Ivan Martinez; Umesh Shaligram; Saurabh Batwal; Rakesh Lothe; Rahul Chandrasekaran; Gaurav Nagar; Meghraj Rajurkar; Harish Rao; Justin R Bevere; Mariette Barbier; J Christopher Love; F Heath Damron
Journal:  mSphere       Date:  2022-08-15       Impact factor: 5.029

8.  Production and secretion of functional SARS-CoV-2 spike protein in Chlamydomonas reinhardtii.

Authors:  Anna Maria Kiefer; Justus Niemeyer; Anna Probst; Gerhard Erkel; Michael Schroda
Journal:  Front Plant Sci       Date:  2022-09-20       Impact factor: 6.627

Review 9.  A critical analysis of SARS-CoV-2 (COVID-19) complexities, emerging variants, and therapeutic interventions and vaccination strategies.

Authors:  Chang-Xing Li; Sobia Noreen; Li-Xue Zhang; Muhammad Saeed; Pei-Feng Wu; Muhammad Ijaz; Dong-Fang Dai; Irsah Maqbool; Asadullah Madni; Faizan Akram; Muhammad Naveed; Jian-Hua Li
Journal:  Biomed Pharmacother       Date:  2021-12-15       Impact factor: 7.419

Review 10.  COVID-19 Genetic Variants and Their Potential Impact in Vaccine Development.

Authors:  Giau Van Vo; Eva Bagyinszky; Seong Soo A An
Journal:  Microorganisms       Date:  2022-03-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.